Melphalan flufenamide 20 mg Injection
RxNorm 2531374
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2531374 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: melphalan flufenamide 20 mg Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Melphalan flufenamide 20 mg Injection
(Atom ID: 12617129)
SY
Synonym (SY):
Melphalan flufenamide (as melphalan flufenamide hydrochloride) 20 mg Injection
(Atom ID: 12617138)
PT
Designated preferred name (PT):
Melphalan flufenamide (as melphalan flufenamide hydrochloride) 20 mg powder for solution for injection vial
(Atom ID: 12726233)
PSN
Prescribable Name (PSN):
Melphalan flufenamide 20 mg Injection
(Atom ID: 12617137)
FN
Full form of descriptor (FN):
Product containing precisely melphalan flufenamide (as melphalan flufenamide hydrochloride) 20 mg/1 vial powder for conventional release solution for injection (clinical drug)
(Atom ID: 12727341)
Patient Education
Melphalan Flufenamide Injection
Melphalan flufenamide injection is used along with dexamethasone to treat multiple myeloma (a type of cancer of the bone marrow) in adults whose disease has returned or has not improved after receiving at least four other chemotherapy medications. Melphalan flufenamide is in a class of medications called alkylating agents. It works by stopping or slowing the growth of cancer cells in your body.
[Learn More]
* Please review the disclaimer below.